Biology · Oct / Nov 2022 · Paper 11 · Question 6
YBI11
As printed in the paper
The question as text
6 Warfarin is an anticoagulant. The dose of warfarin that is given to a patient has to be monitored regularly. This is done by adding thromboplastin to a blood sample and measuring the time it takes for the blood to clot. The result is compared with a control sample and is reported as an International Normalised Ratio (INR) level.
Read automatically from the paper; the printed page above is exact.
Show the answer and mark scheme
6(a)[1]
The only correct answer is C (two)
A is incorrect because thromboplastin is an active enzyme found in the platelets but is not converted into thrombin
B is incorrect because thromboplastin is an active enzyme found in the platelets but is not converted into thrombin
D is incorrect because thromboplastin is an active enzyme found in the platelets but is not converted into thrombin
6(b)[3]
An answer that includes the following points:
1.8 to 3.5 (1)
below 1.8 there is a high risk of stroke (1)
above 3.5 there is an increased risk of bleeding (within the skull) (1)
ACCEPT other ranges {have either high risk
OR
of bleeding or high risk of stroke / both risks
1.8 to 2.5 (1)
are low} = 1 mark if mp 2 and 3 not awarded
below 1.8 there is a high risk of stroke (1)
above 2.5 the risk of bleeding (within the skull) starts to increase (1)
ACCEPT other ranges {have either higher
OR
risk of bleeding or high risk of stroke / both
2.0 to 2.5 (1)
risks are low} = 1 mark if mp 2 and 3 not
awarded
both risks are low / they are the lowest (combination) (1)
3.13.5 has a lower risk of stroke but a higher risk of bleeding (1)
6(c)[3]
An explanation that includes the following points:
warfarin reduces {a blood clot forming / thrombosis} (1)
ACCEPT no blood clots forming
less blood clotting
reduces blood clot (size)
(if a blood clot does not form) it cannot block the coronary artery
if oxygen is supplied to the heart {muscle / cells} it will continue to
{contract / respire} (1)
6(d)(i)[1]
1 012 / 1 013 (1)
6(d)(ii)[4]
An answer that includes the following points:
select a group of patients who have had a heart attack (1)
of similar {age / sex at birth / background / lifestyle} (as in the first
ACCEPT other appropriate factors
study) (1)
no other health issues
give each person the same quantity of warfarin (used in the first
ACCEPT in context of one group
study) (1)
split into two groups
(monitor for) {the same time period / four years} (1)
use of a statistics (1)
ACCEPT description of doubleblind
trial / doubleblind trial / suitable
named statistics test
Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.

